Industry Reports
Aralez Completes Acquisition Of Toprol-XL Â And Its Authorized Generic From AstraZeneca
Aralez Pharmaceuticals Inc a global specialty pharmaceutical company announced that its subsidiary, Aralez Pharmaceuticals Trading DAC (Aralez Ireland), has completed its acquisition of the U.S. rights to Toprol-XL® (metoprolol succinate) and its Authorized Generic (AG) from AstraZeneca. ...
Industry Reports
IMS Health and Quintiles Transnational Holdings Merge completed
Quintiles IMS Holdings has successfully completed its merger of equals transaction between IMS Health Holdings and Quintiles Transnational Holdings. The merger of IMS Health, a global information and technology services company, and Quintiles, a provider of...
Industry Reports
ICU Medical to acquire the Hospira Infusion Systems Business from Pfizer for $1B
ICU Medical will acquire all of Pfizer’s global infusion therapy business, Hospira Infusion Systems (HIS), for $1 billion in cash and stock. The Hospira Infusion Systems business includes IV pumps, solutions, and devices that, when combined...
Industry Reports
PAREXEL Announces Execution of Definitive Agreement to Acquire ExecuPharm
PAREXEL International Corporation , a leading global biopharmaceutical services provider announced that the Company has entered into a definitive agreement to acquire ExecuPharm, Inc , a leading, global functional service provider (FSP) serving the biopharmaceutical industry. ...
Industry Reports
Teva Completes Acquisition of Anda, Inc
Teva Pharmaceutical Industries Ltd announced that it has completed its acquisition of Anda, Inc., a leading distributor of generic pharmaceuticals in the U.S., from Allergan plc. “We are pleased that Anda, Inc., one of the leading...
Industry Reports
Teva Completes Acquisition of Anda Inc
Teva Pharmaceutical Industries Ltd announced that it has completed its acquisition of Anda, Inc., a leading distributor of generic pharmaceuticals in the U.S., from Allergan plc. “We are pleased that Anda, Inc., one of the leading...
Industry Reports
GlaxoSmithKline completes sale of remaining Aspen shares
GlaxoSmithKline has agreed to the sale of 28.2 million ordinary shares in Aspen Pharmacare Holdings Ltd ("Aspen") at a price of ZAR 300 per share (the "Placing Shares"), raising gross proceeds of approximately ZAR 8,470 million. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read